Comparison between Total Intravenous Anesthesia (TIVA) versus Inhalational Anesthesia in Laparoscopic Sleeve Gastrectomy: A Randomized Clinical Trial
,
Abstract
Background: Laparoscopic sleeve gastrectomy (LSG) is a cornerstone of bariatric surgery, requiring optimized anesthesia to ensure patient safety and postoperative recovery. Total Intravenous Anesthesia (TIVA) and inhalational anesthesia are commonly employed, yet their comparative efficacy in LSG remains underexplored. This study evaluates TIVA versus Inhalational Anesthesia in LSG, focusing on recovery time, hospital length of stay (LOS), postoperative nausea and vomiting (PONV), pain scores, and adverse events.
Methods: A randomized clinical trial (RCT) was conducted on 70 patients undergoing LSG between January 2024 and June 2025. The study data were collected in general operating rooms by an anesthesia assistant and colleagues at the Imam Khomaini Hospital Complex of tehran. Patients were randomly assigned to TIVA (n=35) or inhalational (n=35) groups using a computer-generated randomization sequence.
Primary outcomes included recovery time, LOS, and PONV incidence. Secondary outcomes included Visual Analog Scale (VAS) pain scores at 15, 30, 45, and 60 minutes post-surgery and adverse events (hypotension, bradycardia). Data were analyzed using t-tests for continuous variables and chi-square tests for categorical variables, with significance set at p<0.05.
Results: TIVA significantly reduced recovery time (21.1 ± 15.2 vs. 34.6 ± 20.3 minutes, p<0.05) and PONV incidence (20% vs. 34.5%, p<0.01) compared to inhalational anesthesia. VAS scores were lower in the TIVA group at 15 minutes (5.2 ± 1.8 vs. 6.8 ± 1.5, p<0.05) and 30 minutes (5.0 ± 1.7 vs. 6.5 ± 1.6, p<0.05), with no significant differences at 45 or 60 minutes. LOS was comparable (2.4 ± 0.7 vs. 2.7 ± 0.9 days, p=0.15). Subgroup analyses showed TIVA’s superior recovery time in women (p<0.05) and the 30-40 age group (p<0.05). Adverse events were similar between groups.
Conclusion: TIVA offers faster recovery and lower PONV rates compared to inhalational anesthesia in LSG, particularly in women and patients aged 30-40 years. These findings advocate for TIVA as a preferred anesthetic strategy in LSG to enhance postoperative outcomes.
[2] Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013; 23(4):427-36.
[3] Mendonça J, Pereira H, Xará D, Santos A, Abelha FJ. Obese patients: respiratory complications in the post-anesthesia care unit. Rev Port Pneumol. 2014; 20(1):12-9.
[4] Ortiz AC, Atallah AN, Matos D, da Silva EM. Intravenous versus inhalational anaesthesia for paediatric outpatient surgery. Cochrane Database Syst Rev. 2014; (2):CD009015.
[5] Kumar G, Stendall C, Mistry R, Gurusamy K, Walker D. A comparison of total intravenous anaesthesia using propofol with sevoflurane or desflurane in ambulatory surgery: systematic review and meta-analysis. Anaesthesia. 2014; 69(10):1138-50.
[6] Gropper MA, Eriksson LI, Fleisher LA, Wiener-Kronish JP, Cohen NH, Leslie K, et al., editors. Inhaled anesthetics: uptake and distribution. In: Miller's Anesthesia. Elsevier Health Sciences; 2019. p. 528-56.
[7] Gan TJ, Diemunsch P, Habib AS, Kovac A, Kranke P, Meyer TA, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2014; 118(1):85-113. Erratum in: Anesth Analg. 2015; 120(2):494.
[8] Smith I, White PF, Nathanson M, Gouldson R. Propofol: an update on its clinical use. Anesthesiology. 1994; 81(4):1005-43.
[9] Sethi N, Dutta A, S P, Puri GD, Sood J, Chugh P. Gender differences in propofol requirements during total intravenous anesthesia administered by closed-loop anesthesia delivery system: an observational study. Minerva Anestesiol. 2026; 92(3):136-144.
[10] Ingrande J, Lemmens HJ. Dose adjustment of anaesthetics in the morbidly obese. Br J Anaesth. 2010; 105 Suppl 1:i16-23.
[11] White PF. Propofol: its role in changing the practice of anesthesia. Anesthesiology. 2008; 109(6):1132-6.
[12] Apfel CC, Korttila K, Abdalla M, Kerger H, Turan A, Vedder I, et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med. 2004; 350(24):2441-51.
[13] Horn CC, Wallisch WJ, Homanics GE, Williams JP. Pathophysiological and neurochemical mechanisms of postoperative nausea and vomiting. Eur J Pharmacol. 2014; 722:55-66.
[14] Komatsu R, Turan AM, Orhan‐Sungur M, McGuire J, Radke OC, Apfel C. Remifentanil for general anaesthesia: a systematic review. Anaesthesia. 2007; 62(12):1266-80.
[15] Mapleson WW. Effect of age on MAC in humans: a meta-analysis. Br J Anaesth. 1996; 76(2):179-85.
[16] Nguyen NT, Goldman C, Rosenquist CJ, Arango A, Cole CJ, Lee SJ, et al. Laparoscopic Versus Open Gastric Bypass: A Randomized Study of Outcomes, Quality of Life, and Costs. Ann Surg. 2001; 234(3):279-291.
| Files | ||
| Issue | Article in Press |
|
| Section | Research Article(s) | |
| Keywords | ||
| Total Intravenous Anesthesia (TIVA) Inhalations Laparoscopic surgeries Postoperative nausea and vomiting (PONV) Bariatric surgery | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
